Scientific Documentation of 100 Years of Clinical Experience with Fasting for Healthy Longevity at the Buchinger Wilhelmi Clinics
Robin Mesnage
PhD, Scientific Director, Buchinger Wilhelmi, Überlingen, Germany
Dr. Robin Mesnage is the Scientific Director of the Buchinger Wilhelmi Clinics, where he leads research studies to scientifically document the effects of fasting and to integrate cutting-edge diagnostics into the therapeutic journey of patients. He also works in the Department of Nutrition at King’s College London, where he holds a research fellow position to investigate the role of the gut microbiome in the health benefits of plant foods. Additionally, he is a keynote speaker, regularly offering lectures on scientific topics, and has served as an expert on the regulation of human health effects of chemical pollutants for the French government and occasionally for the European Parliament. His research has resulted in the publication of over 100 scientific articles, cited more than 8,000 times. He is among the top 1 percent of cited scientists worldwide for his work on the health effects of pollution.
Scientific Documentation of 100 Years of Clinical Experience with Fasting for Healthy Longevity at the Buchinger Wilhelmi Clinics
Fasting is the most powerful method for enhancing a healthy lifespan. It is a nutritional program for humans and animals that provides body cells with fat as fuel from adipose tissue instead of glucose from food. It also serves repair and regeneration functions, conferring anti-aging effects. The research program at the Buchinger Wilhelmi Clinics leverages 100 years of clinical experience with fasting to document the safety and therapeutic efficacy of the Buchinger Wilhelmi fasting program. In this talk at the Longevity Med Summit, I will provide an overview of the research studies demonstrating how fasting can be used in the treatment of metabolic syndrome and cardiovascular disease, as well as to promote gut health and overall healthy aging. I will also present exclusive results showing how a new at-home fasting program can be a powerful non-pharmacological tool to address the epidemic of chronic metabolic diseases.
